Variability in venom composition of European viper subspecies limits the cross-effectiveness of antivenoms [PDF]
, 2018 Duregotti, Elisa +6 more
core +1 more source
Protective action of varespladib (LY-315929) isolated or associated with antivenon on the local ans sistemic effects induced by the venom of Lachesis muta rhombeata (Surucucu South American) in rats [PDF]
, 2023 Diego Roberto Pereira
openalex
A drug combination therapy consisting of toxin phospholipase A2 and metalloproteinase inhibitors provides preclinical protection against North American Crotalid snakebite envenoming [PDF]
Background Across North America an estimated 3,800–6,500 snakebite envenomings occur annually, resulting in 7–15 deaths and an unknown number of disfigurements and disabilities. Most bites are caused by Crotalid snake species.
Casewell, Nicholas R. +9 more
core
Analytics for assessing the efficacy of snakebite treatment at neutralizing venom toxins [PDF]
, 2021 Xie, Chunfang
core
The Need for Next-Generation Antivenom for Snakebite Envenomation in India. [PDF]
Toxins (Basel), 2023 Vanuopadath M +4 more
europepmc +1 more source
Group X secreted phospholipase A induces lipid droplet formation and prolongs breast cancer cell survival [PDF]
core +1 more source
Reshaping antivenom therapy: A triple-synergy strategy featuring broadly neutralizing antibodies and a small-molecule PLA<sub>2</sub> inhibitor. [PDF]
Acta Pharm Sin BZhou Y, Shi N, Gao X, Luo L.
europepmc +1 more source
Molecular docking analysis of MCL-1 inhibitors for breast cancer management. [PDF]
Bioinformation, 2023 Abdulrahman A +7 more
europepmc +1 more source
The validity, reliability and minimal clinically important difference of the patient specific functional scale in snake envenomation [PDF]
, 2019 et al.,, Mullins, Michael E
core +1 more source